Antihypertensives & Antianginal Drugs Explained

Hypertension silently damages arteries, heart, brain and kidneys, while angina is chest pain from the heart muscle not getting enough oxygen. Antihypertensives lower blood pressure by relaxing vessels, reducing fluid volume, or slowing the heart; antianginal drugs relieve cardiac ischemia by cutting the heart's oxygen demand or raising its supply.

This matters because hypertension affects roughly one in three adults and is the top modifiable risk factor for stroke and heart attack — yet has no symptoms until damage is done. Angina is the warning light for coronary disease. Matching drug class to patient is the core skill of cardiovascular prescribing.

Key Concepts

• ACE inhibitors (enalapril, lisinopril): block angiotensin II, dilating vessels. First-line in hypertension, heart failure, diabetic kidney disease. Dry cough is the signature side effect; never in pregnancy.
• ARBs (losartan, telmisartan): block the angiotensin receptor directly — same benefits with much less cough; the substitute when cough appears.
• Calcium-channel blockers (amlodipine, diltiazem): relax vessel walls; amlodipine is first-line for hypertension. Signature side effect: ankle swelling.
• Thiazide diuretics (hydrochlorothiazide, chlorthalidone): excrete sodium and water — cheap, effective first-line agents. Watch for low potassium.
• Beta-blockers (metoprolol, atenolol): slow the heart and reduce its force. Key in angina and after heart attacks; never stop abruptly.
• Antianginal trio: nitrates (nitroglycerin — dilates coronaries; sublingual tablet relieves attacks within minutes), beta-blockers (cut oxygen demand), calcium-channel blockers (dilate coronaries, cut demand).
• Target: below 140/90 mmHg; below 130/80 for high-risk patients.

How It Works

1. BP equation: BP = cardiac output × peripheral resistance. Diuretics cut volume (output); vasodilators cut resistance.
2. RAAS blockade: ACE inhibitors and ARBs stop angiotensin II constricting vessels and aldosterone retaining salt and water.
3. Vessel relaxation: calcium-channel blockers keep vascular muscle relaxed; nitrates release nitric oxide, dilating coronaries in 1–3 minutes.
4. Demand reduction: beta-blockers slow the heart — a slower heart needs less oxygen, exactly what ischemic muscle needs.
5. Combination logic: two half-doses from different classes lower pressure more than one full dose, with fewer side effects (e.g., ACE inhibitor + calcium-channel blocker + thiazide).

Worked Example

A 58-year-old man has BP 162/102 mmHg despite lifestyle measures. Step 1: repeated readings above 140/90 define hypertension; 162/102 is stage 2. Step 2: start amlodipine 5 mg daily. Step 3: at 4 weeks BP is 148/94 — still above target. Step 4: add lisinopril 10 mg daily (check kidney function and potassium first). Step 5: recheck — 132/84 mmHg, at target. Step 6: counsel — ankle swelling points to amlodipine, dry cough to lisinopril (switch to losartan if it appears), and treatment is lifelong. Two drugs, two mechanisms, one target: stepped-care arithmetic.

Common Misconceptions

• "Feeling fine means pressure is fine." Hypertension is the silent killer — no symptoms until stroke, heart attack or kidney failure. Only the cuff tells the truth.
• "Normal readings mean I can stop tablets." The tablets are the reason readings are normal; stopping — especially beta-blockers — causes rebound.
• "Nitroglycerin cures heart disease." It relieves an attack in minutes but does not fix coronary narrowing; definitive care is lifestyle, statins, antiplatelets, and revascularization where indicated.

Real-World Applications

• Primary care: stepped-care protocols control most hypertension with cheap generics.
• Emergency cardiology: sublingual nitroglycerin plus aspirin is immediate field treatment for suspected angina/heart attack.
• Kidney protection: ACE inhibitors/ARBs slow diabetic kidney damage beyond their pressure effect.
• Post–heart attack: beta-blocker plus ACE inhibitor reduces second events and heart failure.

Antihypertensives lower the BP equation through volume, vessels or heart rate — ACE inhibitors, ARBs, calcium-channel blockers, thiazides and beta-blockers each own one mechanism — and antianginals rebalance the heart's oxygen budget. Match the class to the patient, treat to target, never stop abruptly.